SEC Kicks Off Wide Insider Trading Investigation
The U.S. Securities and Exchange Commission reportedly has launched a broad insider trading investigation of recent deals, including Pfizer Inc.'s acquisition of Wyeth and Eli Lilly & Co.'s purchase of ImClone...To view the full article, register now.
Already a subscriber? Click here to view full article